Reconstitution of industrially important plant biosynthetic pathways into industrial organisms is at the leading edge of the emerging field of synthetic biology. Catalytic or structural elements present in the native plant, but missing from the reconstituted pathway, can result in low yield in the new system, and a manufacturing process that is insufficiently cost effective to be commercially viable. Committed efforts by leading researchers in the field are needed to solve such problems, yet rarely does a product development company have the world’s top researchers on staff to perform such discovery work.
Epimeron works with the best scientists in the field to identify and resolve such bottlenecks, clearing the path for its industrial partners, and facilitating their commercial success. Our custom discovery work, coupled with cost-basis pricing and favourable intellectual property licensing options, can make the difference between failure and success.